1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Analysis Transcriptomics Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-15V8550
Home | Market Reports | Science| Biological Sciences
Global RNA Analysis And Transcriptomics Market Insights Forecast to 2028
BUY CHAPTERS

Global RNA Analysis Transcriptomics Market Research Report 2025

Code: QYRE-Auto-15V8550
Report
March 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

RNA Analysis Transcriptomics Market Size

The global market for RNA Analysis Transcriptomics was valued at US$ 708 million in the year 2024 and is projected to reach a revised size of US$ 1333 million by 2031, growing at a CAGR of 9.6% during the forecast period.

RNA Analysis Transcriptomics Market

RNA Analysis Transcriptomics Market

Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
This report aims to provide a comprehensive presentation of the global market for RNA Analysis Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis Transcriptomics.
The RNA Analysis Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Analysis Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of RNA Analysis Transcriptomics Market Report

Report Metric Details
Report Name RNA Analysis Transcriptomics Market
Accounted market size in year US$ 708 million
Forecasted market size in 2031 US$ 1333 million
CAGR 9.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, Illumina, QIAGEN N.V., F. Hoffmann-La Roche, Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech, Acobiom, GenXPro, CD Genomics, Promega Corporation, Lexogen, Cenix BioScience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of RNA Analysis Transcriptomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is RNA Analysis Transcriptomics Market growing?

Ans: The RNA Analysis Transcriptomics Market witnessing a CAGR of 9.6% during the forecast period 2025-2031.

What is the RNA Analysis Transcriptomics Market size in 2031?

Ans: The RNA Analysis Transcriptomics Market size in 2031 will be US$ 1333 million.

Who are the main players in the RNA Analysis Transcriptomics Market report?

Ans: The main players in the RNA Analysis Transcriptomics Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, Illumina, QIAGEN N.V., F. Hoffmann-La Roche, Danaher Corporation, Fluidigm Corporation, Eurofins Scientific, Sequentia Biotech, Acobiom, GenXPro, CD Genomics, Promega Corporation, Lexogen, Cenix BioScience

What are the Application segmentation covered in the RNA Analysis Transcriptomics Market report?

Ans: The Applications covered in the RNA Analysis Transcriptomics Market report are Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals

What are the Type segmentation covered in the RNA Analysis Transcriptomics Market report?

Ans: The Types covered in the RNA Analysis Transcriptomics Market report are Microarrays, Sequencing, Polymerase Chain Reaction (PCR), RNA Interference

Recommended Reports

RNA Sequencing Markets

Gene Expression Profiling

RNA Therapeutics & Kits

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis Transcriptomics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis Transcriptomics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis Transcriptomics Market Perspective (2020-2031)
2.2 Global RNA Analysis Transcriptomics Growth Trends by Region
2.2.1 Global RNA Analysis Transcriptomics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNA Analysis Transcriptomics Historic Market Size by Region (2020-2025)
2.2.3 RNA Analysis Transcriptomics Forecasted Market Size by Region (2026-2031)
2.3 RNA Analysis Transcriptomics Market Dynamics
2.3.1 RNA Analysis Transcriptomics Industry Trends
2.3.2 RNA Analysis Transcriptomics Market Drivers
2.3.3 RNA Analysis Transcriptomics Market Challenges
2.3.4 RNA Analysis Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis Transcriptomics Players by Revenue
3.1.1 Global Top RNA Analysis Transcriptomics Players by Revenue (2020-2025)
3.1.2 Global RNA Analysis Transcriptomics Revenue Market Share by Players (2020-2025)
3.2 Global RNA Analysis Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA Analysis Transcriptomics Revenue
3.4 Global RNA Analysis Transcriptomics Market Concentration Ratio
3.4.1 Global RNA Analysis Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis Transcriptomics Revenue in 2024
3.5 Global Key Players of RNA Analysis Transcriptomics Head office and Area Served
3.6 Global Key Players of RNA Analysis Transcriptomics, Product and Application
3.7 Global Key Players of RNA Analysis Transcriptomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis Transcriptomics Breakdown Data by Type
4.1 Global RNA Analysis Transcriptomics Historic Market Size by Type (2020-2025)
4.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2026-2031)
5 RNA Analysis Transcriptomics Breakdown Data by Application
5.1 Global RNA Analysis Transcriptomics Historic Market Size by Application (2020-2025)
5.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNA Analysis Transcriptomics Market Size (2020-2031)
6.2 North America RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNA Analysis Transcriptomics Market Size by Country (2020-2025)
6.4 North America RNA Analysis Transcriptomics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis Transcriptomics Market Size (2020-2031)
7.2 Europe RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNA Analysis Transcriptomics Market Size by Country (2020-2025)
7.4 Europe RNA Analysis Transcriptomics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis Transcriptomics Market Size (2020-2031)
8.2 Asia-Pacific RNA Analysis Transcriptomics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2020-2025)
8.4 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis Transcriptomics Market Size (2020-2031)
9.2 Latin America RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNA Analysis Transcriptomics Market Size by Country (2020-2025)
9.4 Latin America RNA Analysis Transcriptomics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis Transcriptomics Market Size (2020-2031)
10.2 Middle East & Africa RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2020-2025)
10.4 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Introduction
11.2.4 Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis Transcriptomics Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies RNA Analysis Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina RNA Analysis Transcriptomics Introduction
11.5.4 Illumina Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.5.5 Illumina Recent Development
11.6 QIAGEN N.V.
11.6.1 QIAGEN N.V. Company Details
11.6.2 QIAGEN N.V. Business Overview
11.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Introduction
11.6.4 QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.6.5 QIAGEN N.V. Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation RNA Analysis Transcriptomics Introduction
11.8.4 Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Details
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Introduction
11.9.4 Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.9.5 Fluidigm Corporation Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Details
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific RNA Analysis Transcriptomics Introduction
11.10.4 Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.10.5 Eurofins Scientific Recent Development
11.11 Sequentia Biotech
11.11.1 Sequentia Biotech Company Details
11.11.2 Sequentia Biotech Business Overview
11.11.3 Sequentia Biotech RNA Analysis Transcriptomics Introduction
11.11.4 Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.11.5 Sequentia Biotech Recent Development
11.12 Acobiom
11.12.1 Acobiom Company Details
11.12.2 Acobiom Business Overview
11.12.3 Acobiom RNA Analysis Transcriptomics Introduction
11.12.4 Acobiom Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.12.5 Acobiom Recent Development
11.13 GenXPro
11.13.1 GenXPro Company Details
11.13.2 GenXPro Business Overview
11.13.3 GenXPro RNA Analysis Transcriptomics Introduction
11.13.4 GenXPro Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.13.5 GenXPro Recent Development
11.14 CD Genomics
11.14.1 CD Genomics Company Details
11.14.2 CD Genomics Business Overview
11.14.3 CD Genomics RNA Analysis Transcriptomics Introduction
11.14.4 CD Genomics Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.14.5 CD Genomics Recent Development
11.15 Promega Corporation
11.15.1 Promega Corporation Company Details
11.15.2 Promega Corporation Business Overview
11.15.3 Promega Corporation RNA Analysis Transcriptomics Introduction
11.15.4 Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.15.5 Promega Corporation Recent Development
11.16 Lexogen
11.16.1 Lexogen Company Details
11.16.2 Lexogen Business Overview
11.16.3 Lexogen RNA Analysis Transcriptomics Introduction
11.16.4 Lexogen Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.16.5 Lexogen Recent Development
11.17 Cenix BioScience
11.17.1 Cenix BioScience Company Details
11.17.2 Cenix BioScience Business Overview
11.17.3 Cenix BioScience RNA Analysis Transcriptomics Introduction
11.17.4 Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.17.5 Cenix BioScience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global RNA Analysis Transcriptomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Microarrays
 Table 3. Key Players of Sequencing
 Table 4. Key Players of Polymerase Chain Reaction (PCR)
 Table 5. Key Players of RNA Interference
 Table 6. Global RNA Analysis Transcriptomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global RNA Analysis Transcriptomics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global RNA Analysis Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global RNA Analysis Transcriptomics Market Share by Region (2020-2025)
 Table 10. Global RNA Analysis Transcriptomics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global RNA Analysis Transcriptomics Market Share by Region (2026-2031)
 Table 12. RNA Analysis Transcriptomics Market Trends
 Table 13. RNA Analysis Transcriptomics Market Drivers
 Table 14. RNA Analysis Transcriptomics Market Challenges
 Table 15. RNA Analysis Transcriptomics Market Restraints
 Table 16. Global RNA Analysis Transcriptomics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global RNA Analysis Transcriptomics Market Share by Players (2020-2025)
 Table 18. Global Top RNA Analysis Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis Transcriptomics as of 2024)
 Table 19. Ranking of Global Top RNA Analysis Transcriptomics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by RNA Analysis Transcriptomics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of RNA Analysis Transcriptomics, Headquarters and Area Served
 Table 22. Global Key Players of RNA Analysis Transcriptomics, Product and Application
 Table 23. Global Key Players of RNA Analysis Transcriptomics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global RNA Analysis Transcriptomics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global RNA Analysis Transcriptomics Revenue Market Share by Type (2020-2025)
 Table 27. Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global RNA Analysis Transcriptomics Revenue Market Share by Type (2026-2031)
 Table 29. Global RNA Analysis Transcriptomics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global RNA Analysis Transcriptomics Revenue Market Share by Application (2020-2025)
 Table 31. Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global RNA Analysis Transcriptomics Revenue Market Share by Application (2026-2031)
 Table 33. North America RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific RNA Analysis Transcriptomics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Thermo Fisher Scientific Company Details
 Table 49. Thermo Fisher Scientific Business Overview
 Table 50. Thermo Fisher Scientific RNA Analysis Transcriptomics Product
 Table 51. Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 52. Thermo Fisher Scientific Recent Development
 Table 53. Bio-Rad Laboratories Company Details
 Table 54. Bio-Rad Laboratories Business Overview
 Table 55. Bio-Rad Laboratories RNA Analysis Transcriptomics Product
 Table 56. Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 57. Bio-Rad Laboratories Recent Development
 Table 58. Merck KGaA Company Details
 Table 59. Merck KGaA Business Overview
 Table 60. Merck KGaA RNA Analysis Transcriptomics Product
 Table 61. Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 62. Merck KGaA Recent Development
 Table 63. Agilent Technologies Company Details
 Table 64. Agilent Technologies Business Overview
 Table 65. Agilent Technologies RNA Analysis Transcriptomics Product
 Table 66. Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 67. Agilent Technologies Recent Development
 Table 68. Illumina Company Details
 Table 69. Illumina Business Overview
 Table 70. Illumina RNA Analysis Transcriptomics Product
 Table 71. Illumina Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 72. Illumina Recent Development
 Table 73. QIAGEN N.V. Company Details
 Table 74. QIAGEN N.V. Business Overview
 Table 75. QIAGEN N.V. RNA Analysis Transcriptomics Product
 Table 76. QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 77. QIAGEN N.V. Recent Development
 Table 78. F. Hoffmann-La Roche Company Details
 Table 79. F. Hoffmann-La Roche Business Overview
 Table 80. F. Hoffmann-La Roche RNA Analysis Transcriptomics Product
 Table 81. F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 82. F. Hoffmann-La Roche Recent Development
 Table 83. Danaher Corporation Company Details
 Table 84. Danaher Corporation Business Overview
 Table 85. Danaher Corporation RNA Analysis Transcriptomics Product
 Table 86. Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 87. Danaher Corporation Recent Development
 Table 88. Fluidigm Corporation Company Details
 Table 89. Fluidigm Corporation Business Overview
 Table 90. Fluidigm Corporation RNA Analysis Transcriptomics Product
 Table 91. Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 92. Fluidigm Corporation Recent Development
 Table 93. Eurofins Scientific Company Details
 Table 94. Eurofins Scientific Business Overview
 Table 95. Eurofins Scientific RNA Analysis Transcriptomics Product
 Table 96. Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 97. Eurofins Scientific Recent Development
 Table 98. Sequentia Biotech Company Details
 Table 99. Sequentia Biotech Business Overview
 Table 100. Sequentia Biotech RNA Analysis Transcriptomics Product
 Table 101. Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 102. Sequentia Biotech Recent Development
 Table 103. Acobiom Company Details
 Table 104. Acobiom Business Overview
 Table 105. Acobiom RNA Analysis Transcriptomics Product
 Table 106. Acobiom Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 107. Acobiom Recent Development
 Table 108. GenXPro Company Details
 Table 109. GenXPro Business Overview
 Table 110. GenXPro RNA Analysis Transcriptomics Product
 Table 111. GenXPro Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 112. GenXPro Recent Development
 Table 113. CD Genomics Company Details
 Table 114. CD Genomics Business Overview
 Table 115. CD Genomics RNA Analysis Transcriptomics Product
 Table 116. CD Genomics Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 117. CD Genomics Recent Development
 Table 118. Promega Corporation Company Details
 Table 119. Promega Corporation Business Overview
 Table 120. Promega Corporation RNA Analysis Transcriptomics Product
 Table 121. Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 122. Promega Corporation Recent Development
 Table 123. Lexogen Company Details
 Table 124. Lexogen Business Overview
 Table 125. Lexogen RNA Analysis Transcriptomics Product
 Table 126. Lexogen Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 127. Lexogen Recent Development
 Table 128. Cenix BioScience Company Details
 Table 129. Cenix BioScience Business Overview
 Table 130. Cenix BioScience RNA Analysis Transcriptomics Product
 Table 131. Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
 Table 132. Cenix BioScience Recent Development
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. RNA Analysis Transcriptomics Picture
 Figure 2. Global RNA Analysis Transcriptomics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global RNA Analysis Transcriptomics Market Share by Type: 2024 VS 2031
 Figure 4. Microarrays Features
 Figure 5. Sequencing Features
 Figure 6. Polymerase Chain Reaction (PCR) Features
 Figure 7. RNA Interference Features
 Figure 8. Global RNA Analysis Transcriptomics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global RNA Analysis Transcriptomics Market Share by Application: 2024 VS 2031
 Figure 10. Academic & Research Institutes Case Studies
 Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
 Figure 12. Hospitals Case Studies
 Figure 13. RNA Analysis Transcriptomics Report Years Considered
 Figure 14. Global RNA Analysis Transcriptomics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global RNA Analysis Transcriptomics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global RNA Analysis Transcriptomics Market Share by Region: 2024 VS 2031
 Figure 17. Global RNA Analysis Transcriptomics Market Share by Players in 2024
 Figure 18. Global Top RNA Analysis Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis Transcriptomics as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by RNA Analysis Transcriptomics Revenue in 2024
 Figure 20. North America RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America RNA Analysis Transcriptomics Market Share by Country (2020-2031)
 Figure 22. United States RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe RNA Analysis Transcriptomics Market Share by Country (2020-2031)
 Figure 26. Germany RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific RNA Analysis Transcriptomics Market Share by Region (2020-2031)
 Figure 34. China RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America RNA Analysis Transcriptomics Market Share by Country (2020-2031)
 Figure 42. Mexico RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa RNA Analysis Transcriptomics Market Share by Country (2020-2031)
 Figure 46. Turkey RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 50. Bio-Rad Laboratories Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 51. Merck KGaA Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 52. Agilent Technologies Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 53. Illumina Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 54. QIAGEN N.V. Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 56. Danaher Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 57. Fluidigm Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 58. Eurofins Scientific Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 59. Sequentia Biotech Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 60. Acobiom Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 61. GenXPro Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 62. CD Genomics Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 63. Promega Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 64. Lexogen Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 65. Cenix BioScience Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart